Barry Cherney

3.2k total citations
46 papers, 2.6k citations indexed

About

Barry Cherney is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Barry Cherney has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Immunology. Recurrent topics in Barry Cherney's work include PARP inhibition in cancer therapy (11 papers), DNA Repair Mechanisms (6 papers) and Protein purification and stability (6 papers). Barry Cherney is often cited by papers focused on PARP inhibition in cancer therapy (11 papers), DNA Repair Mechanisms (6 papers) and Protein purification and stability (6 papers). Barry Cherney collaborates with scholars based in United States, Italy and Netherlands. Barry Cherney's co-authors include Giovanna Tosato, Kishor Bhatia, Amy S. Rosenberg, Mark E. Smulson, Sandra E. Pike, Ghanshyam Das Gupta, Daniela Verthelyi, Julie Teruya‐Feldstein, Ellis Merlin and K Taga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Barry Cherney

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Cherney United States 26 1.6k 866 818 366 217 46 2.6k
Takeshi Takahashi Japan 24 1.0k 0.6× 784 0.9× 1.4k 1.7× 244 0.7× 186 0.9× 75 3.3k
Kenshi Suzuki Japan 30 2.2k 1.4× 1.6k 1.8× 952 1.2× 279 0.8× 292 1.3× 270 4.5k
Renaud Léonard United Kingdom 30 1.3k 0.8× 664 0.8× 468 0.6× 241 0.7× 223 1.0× 100 3.1k
Susan A. Brooks United Kingdom 29 1.8k 1.1× 419 0.5× 610 0.7× 309 0.8× 511 2.4× 88 2.7k
Lyudmila G. Burdelya United States 22 1.2k 0.7× 1.3k 1.5× 1.3k 1.6× 455 1.2× 475 2.2× 35 3.1k
Bita Sahaf United States 25 1.2k 0.7× 507 0.6× 994 1.2× 284 0.8× 129 0.6× 67 2.8k
S. E. Salmon United States 33 1.7k 1.0× 1.9k 2.2× 462 0.6× 404 1.1× 365 1.7× 78 3.9k
Hiro Wakasugi Japan 33 1.5k 0.9× 1.1k 1.2× 1.7k 2.0× 241 0.7× 499 2.3× 90 3.6k
David J. Matthews United States 28 1.3k 0.8× 682 0.8× 1.2k 1.5× 491 1.3× 258 1.2× 61 3.6k
Yongsheng Wang China 27 1.1k 0.7× 1.0k 1.2× 759 0.9× 184 0.5× 398 1.8× 133 2.8k

Countries citing papers authored by Barry Cherney

Since Specialization
Citations

This map shows the geographic impact of Barry Cherney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Cherney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Cherney more than expected).

Fields of papers citing papers by Barry Cherney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Cherney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Cherney. The network helps show where Barry Cherney may publish in the future.

Co-authorship network of co-authors of Barry Cherney

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Cherney. A scholar is included among the top collaborators of Barry Cherney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Cherney. Barry Cherney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenberg, Amy S., Daniela Verthelyi, & Barry Cherney. (2012). Managing uncertainty: A perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins. Journal of Pharmaceutical Sciences. 101(10). 3560–3567. 83 indexed citations
2.
Rosenberg, Aaron S., Barry Cherney, Kurt Brorson, et al.. (2011). Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices. PDA Journal of Pharmaceutical Science and Technology. 65(6). 563–567. 4 indexed citations
3.
Carpenter, John, Barry Cherney, Stacey Ma, et al.. (2010). Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation. Biologicals. 38(5). 602–611. 49 indexed citations
4.
Lee, Sau L., Lawrence X. Yu, Bing Cai, et al.. (2010). Scientific Considerations for Generic Synthetic Salmon Calcitonin Nasal Spray Products. The AAPS Journal. 13(1). 14–19. 15 indexed citations
5.
Kozlowski, Steven, Barry Cherney, & Raymond P. Donnelly. (2009). Hurdles and Leaps for Protein Therapeutics. Annals of the New York Academy of Sciences. 1182(1). 146–160. 3 indexed citations
6.
Carpenter, John F., Theodore W. Randolph, Wim Jiskoot, et al.. (2008). Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality. Journal of Pharmaceutical Sciences. 98(4). 1201–1205. 440 indexed citations
7.
Woodcock, Janet, Rachel E. Behrman, Barry Cherney, et al.. (2007). The FDA's assessment of follow-on protein products: a historical perspective. Nature Reviews Drug Discovery. 6(6). 437–442. 111 indexed citations
8.
Yao, Lei, Sandra E. Pike, Stefania Pittaluga, et al.. (2002). Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin. Cancer Immunology Immunotherapy. 51(7). 358–366. 37 indexed citations
9.
Gutiérrez, Marina, Barry Cherney, Azhar R. Hussain, et al.. (1999). Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.. PubMed. 59(3). 696–703. 52 indexed citations
10.
Bhatia, Kishor, et al.. (1997). Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. Annals of Oncology. 8(10). 987–994. 29 indexed citations
11.
Cherney, Barry, Kishor Bhatia, Cecilia Sgadari, et al.. (1997). Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.. PubMed. 57(12). 2508–15. 44 indexed citations
12.
Taga, K, et al.. (1994). Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells.. Journal of Clinical Investigation. 94(1). 251–260. 69 indexed citations
13.
14.
Taga, K, Barry Cherney, & Giovanna Tosato. (1993). IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. International Immunology. 5(12). 1599–1608. 105 indexed citations
15.
Bhatia, Kishor, Albert J. Fornace, Masue Imaizumi, et al.. (1990). Expression of the poly(ADP-ribose) polymerase gene following natural and induced DNA strand breakage and effect of hyperexpression on DNA repair. Carcinogenesis. 11(1). 123–128. 41 indexed citations
16.
Bhatia, Kishor, Konrad Hüppi, Barry Cherney, et al.. (1990). Relative Predispositional Effect of a PADPRP Marker Allele in B-Cell and Some Non B-Cell Malignancies. Current topics in microbiology and immunology. 166. 347–357. 2 indexed citations
17.
Bhatia, Kishor, Veronica H. Kang, Vicente Notario, et al.. (1990). Cell cycle regulation of an exogenous human poly(ADP‐ribose) polymerase cDNA introduced into murine cells. Journal of Cellular Physiology. 144(2). 345–353. 19 indexed citations
18.
Hüppi, Konrad, et al.. (1989). Sequence and organization of the mouse poly (ADP-ribose) polymerase gene. Nucleic Acids Research. 17(9). 3387–3401. 63 indexed citations
19.
Aldrich, Jane, Barry Cherney, & Charlotte K. Williams. (1988). Sequence analysis of the junction of the large single copy region and the large inverted repeat in the petunia chloroplast genome. Current Genetics. 14(5). 487–492. 11 indexed citations
20.
Midura, Ronald J., Barry Cherney, & Arnold I. Caplan. (1985). The relationship of nicotinamide adenine dinucleotide to the chondrogenic differentiation of limb mesenchymal cells. Developmental Biology. 111(1). 232–242. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Takahashi Breakdown of academic impact, for papers by Kenshi Suzuki Breakdown of academic impact, for papers by Renaud Léonard Breakdown of academic impact, for papers by Susan A. Brooks Breakdown of academic impact, for papers by Lyudmila G. Burdelya Breakdown of academic impact, for papers by Bita Sahaf Breakdown of academic impact, for papers by S. E. Salmon Breakdown of academic impact, for papers by Hiro Wakasugi Breakdown of academic impact, for papers by David J. Matthews Breakdown of academic impact, for papers by Yongsheng Wang
Rankless by CCL
2026